SHANNON FRANCIS: Open Payments
NPI 1710355037 · BOSSIER CITY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,116 in 48 payments from 14 companies in 2025. Trend: 2023 $745 · 2024 $915 · 2025 $1,116
Food & beverage: $1,116
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 14 | $310 |
| Endo USA, Inc. | 8 | $235 |
| Teleflex LLC | 1 | $101 |
| ABBVIE INC. | 4 | $87 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $84 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Ferring Pharmaceuticals Inc. | 3 | $62 |
| Janssen Biotech, Inc. | 2 | $44 |
| Astellas Pharma US Inc | 2 | $39 |
| Photocure Inc | 2 | $29 |
Products named: GEMTESA, XIAFLEX, UROLIFT, Nubeqa, LYNPARZA, ADSTILADRIN, AVEED, ERLEADA.
Industry payments across LA — which companies pay providers there.
